Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Accounts Payable

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Accounts-Payable" stands at 438.98 Billion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Accounts Payable" stands at 438.98 Billion JPY. This represents an increase of 4.20 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.21 percent compared to the value the year prior.
The 1 year change in percent is 6.21.
The 3 year change in percent is 12.96.
The 5 year change in percent is 60.93.
The 10 year change in percent is 178.44.

The Serie's long term average value is 255.53 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 71.79 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2011, to it's latest available value, on 09/30/2025, is +480.28%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -32.38%.

Accounts Payable for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Accounts Payable905,699,262,464.00
LogoJohnson & Johnson - Accounts Payable486,508,953,600.00
LogoAbbVie Inc - Accounts Payable399,570,305,024.00
LogoRoche Holding AG - Accounts Payable317,433,206,677.55
LogoAstraZeneca PLC - Accounts Payable280,205,508,085.11